Anicom Holdings Inc

8715.T

$3.54

Closing

▼-1.44%

1D

▲0.74%

YTD

Market cap

$287.63M

52 week high

$4.57

52 week low

$3.29

Volume

358,800

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$287.63M

Analysts' Rating

BUY

Price Target (Mean)

0.00

Total Analysts

1

P/E

16.65

Operating Margin

0.00%

Beta

1.05

Revenue Growth (Annual)

-

52 week high

$4.57

52 week low

$3.29

Div. Yield

0.73%

EPS Annual Growth

-68.46

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Anicom Holdings Inc is a Japan-based company mainly engaged the non-life insurance business and other businesses. The Non-Life Insurance segment provides underwriting and asset management services for pet insurance. Pet insurance is a policy in which the contractor pays an insurance premium based on an insurance contract, and when the target pet receives medical treatment due to illness or injury during the insurance contract period, the insurance premiums are paid in accordance with the medical terms. Its sales channels are categorized into two channels including agency channels and direct sales channels. The Company is also involved in the animal hospital support business, insurance agency business, as well as the research and clinical business in the animal medicine field.